OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Estimating Vaccine Efficacy Against Transmission via Effect on Viral Load
Lee Kennedy‐Shaffer, Rebecca Kahn, Marc Lipsitch
Epidemiology (2021) Vol. 32, Iss. 6, pp. 820-828
Open Access | Times Cited: 14
Lee Kennedy‐Shaffer, Rebecca Kahn, Marc Lipsitch
Epidemiology (2021) Vol. 32, Iss. 6, pp. 820-828
Open Access | Times Cited: 14
Showing 14 citing articles:
SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impact
Marc Lipsitch, Florian Krammer, Gili Regev‐Yochay, et al.
Nature reviews. Immunology (2021) Vol. 22, Iss. 1, pp. 57-65
Open Access | Times Cited: 305
Marc Lipsitch, Florian Krammer, Gili Regev‐Yochay, et al.
Nature reviews. Immunology (2021) Vol. 22, Iss. 1, pp. 57-65
Open Access | Times Cited: 305
Antinucleocapsid Antibodies After SARS-CoV-2 Infection in the Blinded Phase of the Randomized, Placebo-Controlled mRNA-1273 COVID-19 Vaccine Efficacy Clinical Trial
Dean Follmann, Holly Janes, Olive D. Buhule, et al.
Annals of Internal Medicine (2022) Vol. 175, Iss. 9, pp. 1258-1265
Open Access | Times Cited: 106
Dean Follmann, Holly Janes, Olive D. Buhule, et al.
Annals of Internal Medicine (2022) Vol. 175, Iss. 9, pp. 1258-1265
Open Access | Times Cited: 106
Mucosal Vaccines, Sterilizing Immunity, and the Future of SARS-CoV-2 Virulence
Daniele Focosi, Fabrizio Maggi, Arturo Casadevall
Viruses (2022) Vol. 14, Iss. 2, pp. 187-187
Open Access | Times Cited: 87
Daniele Focosi, Fabrizio Maggi, Arturo Casadevall
Viruses (2022) Vol. 14, Iss. 2, pp. 187-187
Open Access | Times Cited: 87
Interpreting vaccine efficacy trial results for infection and transmission
Marc Lipsitch, Rebecca Kahn
Vaccine (2021) Vol. 39, Iss. 30, pp. 4082-4088
Open Access | Times Cited: 75
Marc Lipsitch, Rebecca Kahn
Vaccine (2021) Vol. 39, Iss. 30, pp. 4082-4088
Open Access | Times Cited: 75
Longitudinal Analysis of SARS-CoV-2 Vaccine Breakthrough Infections Reveals Limited Infectious Virus Shedding and Restricted Tissue Distribution
Ruian Ke, Pamela P. Martinez, Rebecca L. Smith, et al.
Open Forum Infectious Diseases (2022) Vol. 9, Iss. 7
Open Access | Times Cited: 60
Ruian Ke, Pamela P. Martinez, Rebecca L. Smith, et al.
Open Forum Infectious Diseases (2022) Vol. 9, Iss. 7
Open Access | Times Cited: 60
Inferring transmission risk of respiratory viral infection from the viral load kinetics of SARS-CoV-2, England, 2020 to 2021 and influenza A virus, Hong Kong, 2008 to 2012
Jakob Jonnerby, Joe Fenn, Seran Hakki, et al.
Eurosurveillance (2025) Vol. 30, Iss. 6
Open Access
Jakob Jonnerby, Joe Fenn, Seran Hakki, et al.
Eurosurveillance (2025) Vol. 30, Iss. 6
Open Access
Interpreting vaccine efficacy trial results for infection and transmission
Marc Lipsitch, Rebecca Kahn
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 33
Marc Lipsitch, Rebecca Kahn
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 33
SARS-CoV-2 mRNA Vaccine Breakthrough Infections in Fully Vaccinated Healthcare Personnel: A Systematic Review
Caterina Ledda, Claudio Costantino, Giuseppe Motta, et al.
Tropical Medicine and Infectious Disease (2022) Vol. 7, Iss. 1, pp. 9-9
Open Access | Times Cited: 19
Caterina Ledda, Claudio Costantino, Giuseppe Motta, et al.
Tropical Medicine and Infectious Disease (2022) Vol. 7, Iss. 1, pp. 9-9
Open Access | Times Cited: 19
Effectiveness after immunization with BNT162b2 and Gam-COVID-Vac for SARS-CoV-2 and neutralizing antibody titers in health care workers
Melda Emin, Dragan Cibrev, Coskun Kerala, et al.
Turkish Journal of Biochemistry (2024) Vol. 49, Iss. 3, pp. 377-382
Open Access
Melda Emin, Dragan Cibrev, Coskun Kerala, et al.
Turkish Journal of Biochemistry (2024) Vol. 49, Iss. 3, pp. 377-382
Open Access
A potential platform for future vaccine trials identifies high incidence of symptomatic and asymptomatic influenza infection among children aged 6-23 months in South Africa
Cheryl Cohen, Mignon du Plessis, Mignon du Plessis, et al.
The Journal of Infectious Diseases (2024) Vol. 231, Iss. 2, pp. e328-e336
Open Access
Cheryl Cohen, Mignon du Plessis, Mignon du Plessis, et al.
The Journal of Infectious Diseases (2024) Vol. 231, Iss. 2, pp. e328-e336
Open Access
Network methods and design of randomized trials: Application to investigation of COVID-19 vaccination boosters
Victor DeGruttola, Ravi Goyal, Natasha K. Martin, et al.
Clinical Trials (2022) Vol. 19, Iss. 4, pp. 363-374
Open Access | Times Cited: 3
Victor DeGruttola, Ravi Goyal, Natasha K. Martin, et al.
Clinical Trials (2022) Vol. 19, Iss. 4, pp. 363-374
Open Access | Times Cited: 3
Public Health Impacts of Vaccines for COVID-19 and Beyond: Opportunities to Overcome Technical and Regulatory Barriers for Randomized Trials
Lee Kennedy‐Shaffer
American Journal of Public Health (2023) Vol. 113, Iss. 7, pp. 778-785
Closed Access | Times Cited: 1
Lee Kennedy‐Shaffer
American Journal of Public Health (2023) Vol. 113, Iss. 7, pp. 778-785
Closed Access | Times Cited: 1
A joint Bayesian hierarchical model for estimating SARS-CoV-2 genomic and subgenomic RNA viral dynamics and seroconversion
Tracy Qi Dong, Elizabeth R. Brown
Biostatistics (2023) Vol. 25, Iss. 2, pp. 336-353
Open Access | Times Cited: 1
Tracy Qi Dong, Elizabeth R. Brown
Biostatistics (2023) Vol. 25, Iss. 2, pp. 336-353
Open Access | Times Cited: 1
